About Acute megakaryoblastic leukemia in children with Down syndrome
Acute megakaryoblastic leukemia in children with Down syndrome is a rare disease catalogued by Orphanet (ORPHA:99887). It is associated with the GATA1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Acute megakaryoblastic leukemia in children with Down syndrome trials.
Search ClinicalTrials.gov for "Acute megakaryoblastic leukemia in children with Down syndrome" or filter by Orphanet code ORPHA:99887 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Acute megakaryoblastic leukemia in children with Down syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Acute megakaryoblastic leukemia in children with Down syndrome. Updated daily.